Cost-effectiveness of immediate versus postponed intervention for infected necrotizing pancreatitis: planned secondary analysis of the POINTER trial
- PMID: 40276899
- PMCID: PMC12022604
- DOI: 10.1093/bjs/znaf071
Cost-effectiveness of immediate versus postponed intervention for infected necrotizing pancreatitis: planned secondary analysis of the POINTER trial
Figures
References
-
- Boxhoorn L, van Dijk SM, van Grinsven J, Verdonk RC, Boermeester MA, Bollen TL et al. Immediate versus postponed intervention for infected necrotizing pancreatitis. N Engl J Med 2021;385:1372–1381 - PubMed
-
- Slankamenac K, Nederlof N, Pessaux P, de Jonge J, Wijnhoven BP, Breitenstein S et al. The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg 2014;260:757–762; discussion 762–763 - PubMed
-
- EuroQol Research Foundation . EQ-5D-5L User Guide. 2019. https://euroqol.org/publications/user-guides (accessed 8 August 2020)
-
- M Versteegh M, M Vermeulen K, M A A Evers S, de Wit GA, Prenger R, A Stolk E. Dutch tariff for the five-level version of EQ-5D. Value Health 2016;19:343–352 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
